MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s40959-024-00206-4

Медицинская библиотека · Cardio-oncology (London, England) · 2024

Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost.

Koop Yvonne, Atsma Femke, Batenburg Marilot C T, Meijer Hanneke, van der Leij Femke, Gal Roxanne, van Velzen Sanne G M, Išgum Ivana, Vermeulen Hester, Maas Angela H E M, Messaoudi Saloua El, Verkooijen Helena M

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Thoracic radiotherapy may damage the myocardium and arteries, increasing cardiovascular disease (CVD) risk. Women with a high local breast cancer (BC) recurrence risk may receive an additional radiation boost to the tumor bed.

OBJECTIVE

We aimed to evaluate the CVD risk and specifically ischemic heart disease (IHD) in BC patients treated with a radiation boost, and investigated whether this was modified by age.

METHODS

We identified 5260 BC patients receiving radiotherapy between 2005 and 2016 without a history of CVD. Boost data were derived from hospital records and the national cancer registry. Follow-up data on CVD events were obtained from Statistics Netherlands until December 31, 2018. The relation between CVD and boost was evaluated with competing risk survival analysis.

RESULTS

1917 (36.4%) received a boost. Mean follow-up was 80.3 months (SD37.1) and the mean age 57.8 years (SD10.7). Interaction between boost and age was observed for IHD: a boost was significantly associated with IHD incidence in patients younger than 40 years but not in patients over 40 years. The subdistribution hazard ratio (sHR) was calculated for ages from 25 to 75 years, showing a sHR range from 5.1 (95%CI 1.2-22.6) for 25-year old patients to sHR 0.5 (95%CI 0.2-1.02) for 75-year old patients.

CONCLUSION

In patients younger than 40, a radiation boost is significantly associated with an increased risk of CVD. In absolute terms, the increased risk was low. In older patients, there was no association between boost and CVD risk, which is likely a reflection of appropriate patient selection.

Для цитирования: Koop Yvonne, Atsma Femke, Batenburg Marilot C T, Meijer Hanneke, van der Leij Femke, Gal Roxanne, van Velzen Sanne G M, Išgum Ivana, Vermeulen Hester, Maas Angela H E M, Messaoudi Saloua El, Verkooijen Helena M. Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost.. Cardio-oncology (London, England). 2024. DOI: 10.1186/s40959-024-00206-4.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.